Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 21
- DOI:
- No doi available
- Key Word:
- stomach neoplasms;angiotensin-converting enzyme inhibitor;angiotensin H type 1 receptor blocker;lymphangiogenesis
Abstract： Background Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II type 1 receptor blockers (ARB) can inhibit tumor growth by inhibition of angiogenesis.This study was designed to study the anticancer effects of ACEI and ARB on tumor growth and lymphangiogenesis in an implanted gastric cancer mouse model.Methods A model of gastric cancer was established by subcutaneously inoculating human gastric cancer cell line SGC-7901 into 60 nude mice.One week later,all mice were randomly divided into 5 groups.A control group received physiologic saline once daily for 21 days.Mice in the 4 treatment groups received one of the following agents by gavage once daily for 21 days:perindopril,2 mg/kg;captopril,5 mg/kg;Iosartan,50 mg/kg;or valsartan,40 mg/kg.Twenty-one clays after treatment,all the mice were sacrificed and the tumors were removed.Tumor sections were processed,and immunohistochemical methods were used to observe the expressions of vascular endothelial growth factor C (VEGF-C),matrix metalloproteinase 7 (MMP-7),and lymphatic microvessel density (LMVD).Results Tumor volume was significantly inhibited in all ACEI and ARB groups,compared with the control group (all P <0.01).LMVD in the ACEI and ARB groups was also significantly lower than that of the control group (all P<0.01).In the ACEI groups,the expressions of VEGF-C and MMP-7 were both significantly decreased,compared with the control group (all P<0.05).In the ARB groups,expression of VEGF-C was significantly decreased compared with the control group (all P<0.05).However,no significant difference was found in the expression of MMP-7 between ARB groups and the control group.Conclusion In a mouse model,ACEI and ARB might inhibit gastric cancer tumor growth by suppressing lymphangiogenesis.
- [1]Alvarez Vallina L,Sanz L.The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies.[J].2003,9(6).
- [2]Nishio I,Hano T,Imanishi T.Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells.[J].2004,27(2).
- [3]Hurwitz HI,Fernando NH.Targeted therapy of colorectal cancer: clinical experience with bevacizumab.[J].2004,9(Suppl.1).
- [4]Tsujinoue H,Yoshii J,Ikenaka Y,etc.Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.[J].2002,20(6).
- [5]G F M, Strippoli,C, Bonifati,M, Craig,etc.Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.[J].2006,(4).
- [6]Parsons SL,Rowlands BJ,Williams RN,etc.Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.[J].2005,31(9).
- [7]Pineda B,Sotelo J,Garcia Navarrete R,etc.Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma.[J].2005,92(7).
- [8]Murohara T,Sasaki K,Shimada T,etc.Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.[J].2003,112(1).
- [9]R W, Piepho.Overview of the angiotensin-converting-enzyme inhibitors.[J].2000,57 Suppl 1.
- [10]L, Chen,R N, Re,O, Prakash,etc.Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate.[J].1991,196.
- [11]Yuki Saitoh,Hideo Yanai,Tomoko Kitoh,etc.Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer[J].2004,39(5).
- [12]MacKinnon PL,Murray LS,Hole DJ,etc.Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? (see comments)[J].1998,352(9123).
- [13]Yonemura Y,Miwa K,Ajisaka H.Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.[J].2004,51(57).